[6] Zhu G, Pei L, Xia H, Tang Q, Bi F. Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Mol Cancer. 2021;20(1):143. Published 2021 Nov 6. doi:10.1186/s12943-021-01441-...
2. Cervantes A, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023 Jan;34(1):10-32. 3. Zhu G, et al. Role of oncogenic KRAS in the ...
Moreover, the department has valuable clinical experience in testing and preventing exposure to infectious diseases, as well as the diagnosis and treatment of fever of unknown origin. Hepatitis Clinic Services: The Hepatitis Clinic provides diagnosis and treatment of various liver diseases, including ...
Liver cancer.Chronic hepatitis C increases your chance of developing liver cancer. If you develop cirrhosis, you'll still be at an increased risk for liver cancer, even if you have treatment and are cured. Your doctor will likely recommend you have blood tests and liver ultrasounds periodically...
METHOD FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF PROSTATE CANCER METASTASIS USING C-MAFSolve the problems, such as: provide it is a kind of for diagnosing, prognosis and treatment prostate cancer with osseous metastasis use c-MAF.ロジェル ゴミス...
(1952), Cancer of the colon and rectum. Its Diagnosis and Treatment. By Fred W. Rankin, B.A., M.A., M.D., LL.D., Sc.D., F.A.C.S., and A. Stephens Graham, M.D., M.S., F.A.C.S. Second edition. 6 × 9¼ in. Pp. 427 + xiv, with 148 illustrations. 195...
(ER−) of the oestrogen receptor1. Approximately 80% of newly diagnosed breast cancers are ER+ although this proportion varies with age at diagnosis and ethnicity1. The majority of breast cancer GWAS risk loci have been identified on the basis of their association with overall breast cancer ...
There is little evidence that dietary supplements are beneficial for patients with breast cancer; therefore, they are usually not recommended by treatment guidelines. The aim of the present analysis was to assess the prevalence of dietary supplement (DS)
Conclusions Our data revealed the role of LINC00623/NAT10 signaling axis in PDAC progression, showing that it is a potential biomarker and therapeutic target for PDAC.Similar content being viewed by others LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD...
Sometimes, aClostridium difficileinfection can come back. Studies have shown that the people most at risk for a recurrence ofC. diffare: Older (average age 70) Female or people assigned female at birth Those with a history of cancer